Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#131 / 200 Total
NUWE - Nuwellis Inc - Stock Price Chart
TickerNUWE [NASD]
CompanyNuwellis Inc
CountryUSA
IndustryMedical Devices
Market Cap0.78MEPS (ttm)-765.92
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y90.39%
P/S0.09EPS next 5Y-
P/B0.20EPS Q/Q96.73%
Dividend-Sales Q/Q2.53%
Insider Own36.36%Inst Own2.89%
Insider Trans0.00%Inst Trans-
Short Float5.86%EarningsMay 13/b
Analyst Recom1.00Target Price462.00
Avg Volume249.61K52W Range6.73 - 197.40
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
NAKA - Kindly MD Inc - Stock Price Chart
TickerNAKA [NASD]
CompanyKindly MD Inc
CountryUSA
IndustryMedical Care Facilities
Market Cap93.60MEPS (ttm)-0.73
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S37.90EPS next 5Y-
P/B48.44EPS Q/Q-262.74%
Dividend-Sales Q/Q-30.08%
Insider Own66.75%Inst Own13.13%
Insider Trans0.00%Inst Trans19.69%
Short Float21.57%Earnings-
Analyst Recom-Target Price-
Avg Volume2.78M52W Range0.65 - 34.77
Kindly MD, Inc. is a patient-first healthcare and healthcare data company, which engages in redefining value-based care and patient-centered medical services. Its services include mental health, medical card, medication management, sleep support, pain treatment, and weight loss. The company was founded by Timothy Pickett on December 2, 2019 and is headquartered in Murray, UT.
DNA - Ginkgo Bioworks Holdings Inc - Stock Price Chart
TickerDNA [NYSE, RUT]
CompanyGinkgo Bioworks Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap584.15MEPS (ttm)-8.99
P/E-EPS this Y41.87%
Forward P/E-EPS next Y20.73%
PEG-EPS past 5Y-27.97%
P/S2.46EPS next 5Y-
P/B0.80EPS Q/Q49.35%
Dividend-Sales Q/Q27.34%
Insider Own31.28%Inst Own56.95%
Insider Trans-0.03%Inst Trans-0.71%
Short Float31.50%EarningsMay 06/a
Analyst Recom3.75Target Price8.67
Avg Volume1.29M52W Range5.00 - 16.85
Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Che AustinOfficerJul 09 '25Proposed Sale11.182,20024,596Jul 09 12:07 PM
Che AustinOfficerJun 23 '25Proposed Sale8.4399835Jun 23 09:54 AM
Che AustinOfficerJun 20 '25Proposed Sale8.6699857Jun 20 09:50 AM
Che AustinOfficerJun 18 '25Proposed Sale8.4699838Jun 18 09:41 AM
Che AustinOfficerJun 17 '25Proposed Sale9.0699897Jun 17 11:58 AM
IKT - Inhibikase Therapeutics Inc - Stock Price Chart
TickerIKT [NASD, RUT]
CompanyInhibikase Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap137.53MEPS (ttm)-1.64
P/E-EPS this Y65.52%
Forward P/E-EPS next Y-8.75%
PEG-EPS past 5Y18.99%
P/S-EPS next 5Y30.17%
P/B1.60EPS Q/Q79.16%
Dividend-Sales Q/Q-
Insider Own38.78%Inst Own54.55%
Insider Trans0.00%Inst Trans13.78%
Short Float7.17%EarningsMay 14/a
Analyst Recom1.00Target Price8.00
Avg Volume252.65K52W Range1.12 - 4.20
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. It also focuses on neurodegeneration and its lead program IkT-148009, an Abelson Tyrosine Kinase (c-Abl) inhibitor, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Ableson Tyrosine Kinases. The company was founded by Milton H. Werner in September 2008 and is headquartered in Atlanta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bellini RobertoDirectorOct 21 '24Buy1.371,460,0002,000,2001,460,000Oct 23 07:53 PM
Kush ArvindDirectorOct 21 '24Buy1.37145,000198,650145,000Oct 23 07:49 PM
Munshi AmitDirectorOct 21 '24Buy1.37365,000500,050365,000Oct 23 07:43 PM
QBTS - D-Wave Quantum Inc - Stock Price Chart
TickerQBTS [NYSE, RUT]
CompanyD-Wave Quantum Inc
CountryUSA
IndustryComputer Hardware
Market Cap4.63BEPS (ttm)-0.60
P/E-EPS this Y56.84%
Forward P/E-EPS next Y4.95%
PEG-EPS past 5Y-0.61%
P/S216.65EPS next 5Y32.49%
P/B20.81EPS Q/Q82.39%
Dividend-Sales Q/Q508.56%
Insider Own5.38%Inst Own29.02%
Insider Trans-56.37%Inst Trans-1.57%
Short Float20.51%EarningsMay 08/b
Analyst Recom1.00Target Price16.57
Avg Volume65.87M52W Range0.75 - 19.76
D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company's quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nielsen KirstjenDirectorJun 12 '25Sale16.2158,644950,854132,673Jun 16 08:50 PM
Nielsen KirstjenDirectorJun 16 '25Sale16.0413,000208,520119,673Jun 16 08:50 PM
DiLullo John DDirectorJun 13 '25Sale15.1222,000332,66259,295Jun 16 08:50 PM
DiLullo John DDirectorJun 12 '25Sale16.2020,000324,08081,295Jun 16 08:50 PM
DiLullo John DDirectorJun 16 '25Sale16.4015,000246,06044,295Jun 16 08:50 PM
OSIS - OSI Systems, Inc - Stock Price Chart
TickerOSIS [NASD, RUT]
CompanyOSI Systems, Inc
CountryUSA
IndustryElectronic Components
Market Cap3.57BEPS (ttm)8.22
P/E25.88EPS this Y14.60%
Forward P/E21.20EPS next Y7.71%
PEG2.33EPS past 5Y16.36%
P/S2.11EPS next 5Y11.10%
P/B4.06EPS Q/Q22.70%
Dividend-Sales Q/Q9.61%
Insider Own6.14%Inst Own119.99%
Insider Trans-8.13%Inst Trans10.32%
Short Float13.39%EarningsMay 01/b
Analyst Recom1.33Target Price243.33
Avg Volume207.25K52W Range129.18 - 241.64
OSI Systems, Inc. engages in the design and manufacture of specialized electronic systems, and components for critical applications. It operates through the following segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment includes security inspection systems and related services, and turnkey security screening solutions. The Healthcare segment provides patient monitoring, diagnostic cardiology, and related services. The Optoelectronics and Manufacturing segment refers to electronic components and electronic manufacturing services. The company was founded by Deepak Chopra in May 1987 and is headquartered in Hawthorne, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LUSKIN MEYER/DirectorJun 12 '25Sale237.151,000237,15011,214Jun 13 06:25 PM
LUSKIN MEYER/DirectorJun 12 '25Proposed Sale236.681,000236,680Jun 12 06:30 PM
Ballhaus William Francis JRDirectorMay 21 '25Sale228.88750171,66024,055May 22 05:13 PM
BALLHAUS TRUSTDirectorMay 21 '25Proposed Sale228.88750171,660May 21 04:13 PM
EDRICK ALAN IEVP & CFOMay 13 '25Sale229.0020,0004,580,000284,953May 15 06:00 PM
MDAI - Spectral AI Inc - Stock Price Chart
TickerMDAI [NASD]
CompanySpectral AI Inc
CountryUSA
IndustryMedical Devices
Market Cap73.64MEPS (ttm)-0.55
P/E-EPS this Y81.90%
Forward P/E-EPS next Y-159.16%
PEG-EPS past 5Y-
P/S2.46EPS next 5Y20.68%
P/B-EPS Q/Q157.57%
Dividend-Sales Q/Q6.02%
Insider Own44.02%Inst Own10.44%
Insider Trans0.00%Inst Trans3.62%
Short Float4.89%EarningsMay 13/a
Analyst Recom1.00Target Price5.11
Avg Volume409.31K52W Range0.82 - 3.25
Spectral AI, Inc. is a predictive artificial intelligence company. It focuses on medical diagnostics for accurate treatment decisions in wound care for burn, DFU, and future clinical applications. Its DeepView platform is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company was founded by John Michael DiMaio and Wen Sheng Fan on November 17, 2020 and is headquartered in Dallas, TX.
OSCR - Oscar Health Inc - Stock Price Chart
TickerOSCR [NYSE, RUT]
CompanyOscar Health Inc
CountryUSA
IndustryHealthcare Plans
Market Cap3.66BEPS (ttm)0.28
P/E51.62EPS this Y232.58%
Forward P/E22.41EPS next Y92.90%
PEG0.36EPS past 5Y-
P/S0.36EPS next 5Y144.44%
P/B2.73EPS Q/Q47.21%
Dividend-Sales Q/Q42.20%
Insider Own29.26%Inst Own61.64%
Insider Trans-0.03%Inst Trans-3.61%
Short Float15.87%EarningsMay 07/b
Analyst Recom3.00Target Price16.31
Avg Volume15.45M52W Range11.20 - 23.79
Jul-11-25Downgrade Wells Fargo Equal Weight → Underweight $10
Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RANMALI BOPITIYAOfficerJun 20 '25Proposed Sale18.7730,000563,100Jun 20 04:25 PM
ALESSANDREA QUANEFormer OfficerMay 16 '25Proposed Sale17.52148,2802,598,488May 16 04:16 PM
Robinson Elbert O. Jr.DirectorMay 12 '25Sale16.4325,000410,75064,512May 14 04:20 PM
ALESSANDREA QUANEFormer OfficerMay 14 '25Proposed Sale17.513005,252May 14 04:17 PM
ELBERT O ROBINSONDirectorMay 12 '25Proposed Sale16.4325,000410,798May 12 04:09 PM
GDYN - Grid Dynamics Holdings Inc - Stock Price Chart
TickerGDYN [NASD, RUT]
CompanyGrid Dynamics Holdings Inc
CountryUSA
IndustryInformation Technology Services
Market Cap898.74MEPS (ttm)0.13
P/E81.27EPS this Y-4.51%
Forward P/E20.70EPS next Y14.40%
PEG5.66EPS past 5Y-36.62%
P/S2.42EPS next 5Y14.37%
P/B1.74EPS Q/Q164.09%
Dividend-Sales Q/Q25.81%
Insider Own6.89%Inst Own81.90%
Insider Trans-7.23%Inst Trans-2.78%
Short Float5.29%EarningsMay 01/a
Analyst Recom1.00Target Price18.25
Avg Volume671.22K52W Range10.42 - 25.50
Grid Dynamics Holdings, Inc. engages in the provision of technology consulting, platform and product engineering, and advanced analytics services. It operates through the following geographical segments: United States, United Kingdom, Netherlands, and Other. The company was founded by Victoria Livschitz in 2006 and is headquartered in San Ramon, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Livschitz LeonardCHIEF EXECUTIVE OFFICERJul 08 '25Sale12.5020,000250,0002,907,279Jul 10 04:16 PM
Gryzlov YuryCHIEF OPERATING OFFICERJul 08 '25Sale12.332,00024,660467,779Jul 10 04:15 PM
Doradla AnilCHIEF FINANCIAL OFFICERJul 07 '25Sale12.222,00024,440354,388Jul 08 04:15 PM
LEONARD LIVSCHITZOfficerJul 08 '25Proposed Sale12.5020,000249,921Jul 08 04:06 PM
YURY GRYZLOVOfficerJul 08 '25Proposed Sale12.332,00024,660Jul 08 04:04 PM
ZBIO - Zenas Biopharma Inc - Stock Price Chart
TickerZBIO [NASD, RUT]
CompanyZenas Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap467.71MEPS (ttm)-3.98
P/E-EPS this Y66.58%
Forward P/E-EPS next Y6.09%
PEG-EPS past 5Y-
P/S31.18EPS next 5Y32.39%
P/B1.64EPS Q/Q-10.71%
Dividend-Sales Q/Q-
Insider Own75.62%Inst Own32.99%
Insider Trans0.11%Inst Trans4.31%
Short Float50.00%EarningsMay 15/b
Analyst Recom1.00Target Price32.33
Avg Volume175.83K52W Range5.83 - 26.25
Jun-20-25 04:15PM Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-13-25 05:45AM Zenas BioPharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ZBIO (PR Newswire) -8.75%
Jun-02-25 04:00AM ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO (PR Newswire) +5.67%
May-29-25 07:05AM Zenas BioPharma to Present at the Jefferies Global Healthcare Conference (GlobeNewswire) +8.34%
May-28-25 09:31AM ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO (PR Newswire) -12.59%
May-16-25 05:45AM Investors in Zenas BioPharma, Inc. Should Contact Levi & Korsinsky Before June 16, 2025 to Discuss Your Rights - ZBIO (PR Newswire) +7.49%
May-15-25 07:05AM Zenas BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Updates (GlobeNewswire) +12.21%
May-06-25 05:45AM Zenas BioPharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ZBIO (PR Newswire) -19.71%
May-02-25 05:45AM Shareholders of Zenas BioPharma, Inc. Should Contact Levi & Korsinsky Before June 16, 2025 to Discuss Your Rights - ZBIO (PR Newswire)
Apr-29-25 05:45AM Zenas BioPharma, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before June 16, 2025 to Discuss Your Rights - ZBIO (PR Newswire) +12.56%
Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MOULDER LEON O JRChief Executive OfficerFeb 18 '25Buy6.6725,000166,750266,155Feb 19 04:01 PM
Xiao TingDirectorFeb 07 '25Buy7.7610,00077,60047,000Feb 11 04:20 PM
MOULDER LEON O JRChief Executive OfficerDec 04 '24Buy9.9845,000449,100241,155Dec 04 09:03 PM
MOULDER LEON O JRChief Executive OfficerDec 03 '24Buy10.7625,000269,000196,155Dec 04 09:03 PM
MOULDER LEON O JRChief Executive OfficerNov 18 '24Buy15.007,500112,500168,655Nov 20 05:20 PM
191011121314151617181920